Abstract
The digitalis glycosides are potent cardiovascular drugs with a low therapeutic index and a high incidence of iatrogenic complications. Digoxin is the most commonly used preparation. Common indications include rate control in atrial fibrillation, as well as the treatment of other atrial tachyarrhythmias, and low-output congestive heart failure. Digitalis is contraindicated in idiopathic hypertrophic subaortic stenosis (unless atrial fibrillation is present) and in some patients with Wolff-Parkinson-White syndrome.
摘要
洋地黄苷类是强效心血管药物，治疗指数低，医源性并发症发生率高。地高辛是最常用的制剂。常见适应证包括控制房颤的心率，以及治疗其他房性快速心律失常和低输出量性充血性心力衰竭。洋地黄在特发性肥厚性主动脉瓣下狭窄（除非存在房颤）和一些 Wolff-Parkinson-White 综合征患者中禁用。
相似文献
1
Digitalis glycosides.洋地黄苷类
Am Fam Physician. 1983 Nov;28(5):206-16.
2
Digitalis glycosides. I.洋地黄苷。一。
N Engl J Med. 1973 Apr 5;288(14):719-22. doi: 10.1056/NEJM197304052881407.
3
Interactions of digitalis.洋地黄的相互作用。
Can Med Assoc J. 1979 Aug 4;121(3):263-4.
4
Digitalis glycosides. 2.洋地黄苷。2.
N Engl J Med. 1973 May 3;288(18):942-6. doi: 10.1056/NEJM197305032881805.
5
Cardiac glycosides: digitalis, digoxin, and digitoxin.强心苷类：洋地黄、地高辛和洋地黄毒苷。
Am J Med Technol. 1978 Sep;44(9):896-904.
6
Current concepts in the use of digitalis.洋地黄使用的当前概念
Adv Intern Med. 1989;34:425-54.
7
The capacity of different digitalis materials to induce ventricular rhythm disturbances in the reserpine-pretreated cat.不同洋地黄制剂在利血平预处理猫中诱发心室节律紊乱的能力。
J Pharmacol Exp Ther. 1967 Apr;156(1):159-65.
8
Digitalis glycosides--recent advances in clinical pharmacology and treatment.洋地黄苷类——临床药理学与治疗的最新进展
South Med J. 1977 Apr;70(4):470-6. doi: 10.1097/00007611-197704000-00032.
9
Clinical pharmacology of digitalis glycosides.洋地黄苷类的临床药理学
Annu Rev Med. 1975;26:159-71. doi: 10.1146/annurev.me.26.020175.001111.
10
Clinical pharmacology and therapeutics use of digitalis glycosides.洋地黄苷类的临床药理学与治疗应用
Drugs. 1973;6(3):182-221. doi: 10.2165/00003495-197306030-00005.
Zotero 插件